title: Gabapentin can improve dystonia in confirmed Wilson disease.
authors.forename: Margherita
authors.initials: M
authors.lastname: Lerose
authors.forename: Roberto
authors.initials: R
authors.lastname: Di Fabio
authors.forename: Mariano
authors.initials: M
authors.lastname: Serrao
authors.forename: Georgios
authors.initials: G
authors.lastname: Loudianos
authors.forename: Francesco
authors.initials: F
authors.lastname: Pierelli
authors.forename: Carlo
authors.initials: C
authors.lastname: Casali
mesh_terms: D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D000077206:Gabapentin; D006527:Hepatolenticular Degeneration / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000588:Amines; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin